Clinical Trials Browser

Phase 2 × pemigatinib × Other solid neoplasm × Clear all

NCT06653777 2025-06-05

AcSé PEMI

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Miscellaneous

NCT06022289 2023-09-01

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor